Study | Country | Method | Prostate cancer | Prostate non cancer controls | P value |
---|---|---|---|---|---|
Monini 1995 BKV [132] | Italy | PCR | 4/7 57% | 11/19 58% | 0.986 ns Benign > cancer |
Zambrano 2002 BKV [133] | US | PCR | 2/8 25% | 1/11 9% | 0.427Â ns |
Zambrano 2002 JCV [133] | US | PCR | 3/8 38% | 4/11 36% | 0.973Â ns |
Bergh 2007 JCV [97] | Sweden | PCR | 3/159 2% | 6/159 4% | 0.324 ns Benign > cancer |
Lau 2007 BKV [134] | US | ISH | 2/30 7% | 4/30 13% | 0.481 ns Benign > cancer |
Das 2008 BKV [135] | US | ISH | 11/14 79% | 4/15 27% | 0.090Â ns |
Russo 2008 BKV [136] | Italy | IHC | 20/26 77% | 0/12 0% | 0.004Â s |
Delbue 2013 BKV [137] | Italy | PCR | 18/56 32% | 15/68 22% | 0.318Â ns |
Delbue 2013 JCV [137] | Italy | PCR | 16/56 28% | 16/68 24% | 0.624Â ns |
Taghavi 2015 BKV [138] | Iran | PCR | 17/60 28% | 9/60 15% | 0.154Â ns |
Gorish 2019 BKV [139] | Sudan | Immunofluoresence PCR | 17/55 30% 16/17 94% | 4/55 7% 2/4 50% | 0.009Â s 0.493Â ns |